Nothing Special   »   [go: up one dir, main page]

Shah et al., 2010 - Google Patents

Formulation and evaluation of transdermal patches of papaverine hydrochloride

Shah et al., 2010

View PDF
Document ID
9407386518414903988
Author
Shah S
Rahul J
Prabhakar P
Publication year
Publication venue
Asian Journal of Pharmaceutics (AJP)

External Links

Snippet

Formulation and evaluation of transdermal patches of papaverine hydrochloride Page 1 Asian Journal of Pharmaceutics - January-March 2010 79 INTRODUCTION A recent approach to drug delivery is to deliver the drug into systemic circulation at predetermined rate using skin as a site …
Continue reading at asiapharmaceutics.info (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
    • A61K47/08—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycol [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30—Macromolecular compounds
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30—Macromolecular compounds
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30—Macromolecular compounds
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar, pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Similar Documents

Publication Publication Date Title
Shinde et al. Development and characterization of transdermal therapeutics system of tramadol hydrochloride
Koland et al. In vitro and in vivo evaluation of chitosan buccal films of ondansetron hydrochloride
Prabhakara et al. Preparation and evaluation of transdermal patches of papaverine hydrochloride
Prabhu et al. Formulation development and investigation of domperidone transdermal patches
Shivalingam et al. Formulation and evaluation of transdermal patches of pantoprazole sodium
Hardainiyan et al. Design, formulation and in vitro drug release from transdermal patches containing imipramine hydrochloride as model drug
Bhatia et al. Formulation and evaluation of transdermal patch of pregabalin
Singh et al. Mucoadhesive bilayer buccal patches of Verapamil hydrochloride: Formulation development and characterization
Shah et al. Formulation and evaluation of transdermal patches of papaverine hydrochloride
Latha et al. Formulation, Optimization and Evaluation of Glibenclamide Transdermal Patches by using chitosan Polymer
Singh et al. Design, formulation and in vitro drug release from transdermal patches containing Nebivolol hydrochloride as model drug
Chourasia et al. Formulation and evaluation of matrix transdermal patches of meloxicam
Patel et al. Formulation and evaluation of drug-free ophthalmic films prepared by using various synthetic polymers
Soujanya et al. Formulation and in vitro & in vivo evaluation of transdermal patches of lornoxicam using natural permeation enhancers
Sharma et al. Design and evaluation of Olanzapine transdermal patches containing vegetable oils as permeation enhancers
Rai et al. Formulation and evaluation of polymeric transdermal patch of meloxicam
Jatav et al. Formulation and Evaluation of Transdermal Patches of Nebivolol Hydrochloride
Dhama et al. Development and characterization of transdermal patches of tramadol hydrochloride: An approach to pain management
Behin et al. Development of matrix dispersion transdermal therapeutic system containing glipizide
Umekar et al. Formulation development and evaluation of transdermal drug delivery system of antihypertensive drug
Banu et al. Formulation and evaluation of transdermal drug delivery systems of ivabradine hydrochloride
Bagchi et al. Formulation, In-vitro Evaluations and Skin Irritation Study of Losartan Potassium Transdermal Patches: Formulation of losartan transdermal patches
Chathoth et al. Effect of penetration enhancers on the permeability characteristics of lisinopril transdermal delivery systems
Arun Formulation evaluation and in vitro permeation studies of transdermal nifedipine from matrix types patches
Samal et al. Development and characterization of transdermal patches of metoprolol succinate